Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Apparentness of Unseen Rejection Episodes Post Lung rLTx Is Reliably Enabled by ddcfDNA Detection. Local targets link to admitted publications; unresolved targets remain external evidence.
Lung Transplantation: Indications, Follow‐Up Care and Long‐Term Results
2025 · External reference
Graft Survival in Primary Thoracic Organ Transplant Recipients: A Special Report From the International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation
10.1016/j.healun.2023.07.017 · 2023 · External reference
Unresolved reference
2024 · External reference
Epidemiology, Risk Factors, and Outcomes of Lung Retransplantation: An Analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry
10.1016/j.healun.2020.01.1122 · 2020 · External reference
Retransplantation Outcomes at a Large Lung Transplantation Program
10.1097/txd.0000000000000844 · 2018 · External reference
Lung Retransplantation During the Lung Allocation Score Era: Outcomes From a Large Single Center
10.1016/j.jhlto.2026.100501 · 2026 · External reference
Functional Status Is Highly Predictive of Outcomes After Redo Lung Transplantation: An Analysis of 390 Cases in the Modern Era
10.1016/j.athoracsur.2013.05.080 · 2013 · External reference
Lung Retransplantation in the Modern Era
10.21037/jtd-2021-25 · 2021 · External reference
Technique and Outcomes of Less Invasive Lung Retransplantation
10.1097/tp.0000000000001905 · 2018 · External reference
Early Donor‐Specific Antibodies in Lung Transplantation: Risk Factors and Impact on Survival
10.1016/j.healun.2014.06.015 · 2014 · External reference
Implications for Human Leukocyte Antigen Antibodies After Lung Transplantation: A 10‐Year Experience in 441 Patients
10.1378/chest.12-0587 · 2013 · External reference
Impact of Transient and Persistent Donor‐Specific Antibodies in Lung Transplantation
10.3389/ti.2024.12774 · 2024 · External reference
De Novo DQ Donor‐Specific Antibodies Are Associated With Chronic Lung Allograft Dysfunction After Lung Transplantation
10.1164/rccm.201509-1857oc · 2016 · External reference
Antibody‐Mediated Rejection and Sponge Effect in a Redo Lung Transplant Recipient
2021 · External reference
Lung Intragraft Donor‐Specific Antibodies as a Risk Factor for Graft Loss
10.1016/j.healun.2016.06.010 · 2016 · External reference
Intragraft Donor‐Specific Anti‐HLA Antibodies in Phenotypes of Chronic Lung Allograft Dysfunction
10.1183/13993003.00847-2019 · 2019 · External reference
The Impact of Non‐HLA Antibodies on Outcomes After Lung Transplantation and Implications for Therapeutic Approaches
10.1016/j.humimm.2019.04.008 · 2019 · External reference
The Importance of Non‐HLA Antibodies in Transplantation
10.1038/nrneph.2016.88 · 2016 · External reference
Antigen and Cell‐Based Assays for the Detection of Non‐HLA Antibodies
10.3389/fimmu.2022.864671 · 2022 · External reference
Donor‐Derived Cell‐Free DNA for Detection of Acute Rejection in Lung Transplant Recipients
10.3389/fimmu.2025.1531774 · 2025 · External reference
Association of Local Intrapulmonary Production of Antibodies Specific to Donor Major Histocompatibility Complex Class I With the Progression of Chronic Rejection of Lung Allografts
10.1097/tp.0000000000001665 · 2017 · External reference
Influence of HLA Mismatch Between Donors and Recipients on Postoperative Outcomes in Cadaveric Lung Transplantation
10.1007/s11748-024-02109-8 · 2025 · External reference
Renal Transplant Outcomes and De Novo Donor‐Specific Anti‐Human Leukocyte Antigen Antibodies: A Systematic Review
10.1093/ndt/gfy077 · 2018 · External reference
Donor‐Derived Cell‐Free DNA Accurately Detects Acute Rejection in Lung Transplant Patients, a Multicenter Cohort Study
10.1016/j.healun.2021.04.009 · 2021 · External reference
Donor Derived Cell Free DNA in Lung Transplant Recipients Rises in Setting of Allograft Instability
10.3389/frtra.2024.1497374 · 2024 · External reference
Donor‐Derived Cell‐Free DNA Predicts Allograft Failure and Mortality After Lung Transplantation
10.1016/j.ebiom.2018.12.029 · 2019 · External reference
Extreme Elevations of Donor‐Derived Cell‐Free DNA Increases the Risk of Chronic Lung Allograft Dysfunction and Death, Even Without Clinical Manifestations of Disease
10.1016/j.healun.2024.04.064 · 2024 · External reference
Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial
10.1164/rccm.202305-0798oc · 2024 · External reference
A Meta‐Analysis of Graft Survival, Patient Survival and Delayed Graft Function in First‐Time and Repeat Kidney Transplants
10.1093/ndt/gfaf066 · 2025 · External reference
Outcomes and Allograft Survival of Patients Who Underwent a Second Kidney Transplant and Were Followed Up for 10 Years
10.1016/j.transproceed.2022.04.006 · 2022 · External reference
First and Second Kidney Transplantations From Living Donors Offer Comparable Outcomes for Patients
10.4285/kjt.22.0018 · 2022 · External reference
Calling Time on Spirometry: Unlocking the Silent Zone in Acute Rejection After Lung Transplantation
10.1164/rccm.202003-0581ed · 2020 · External reference
Late Manifestation of Alloantibody‐Associated Injury and Clinical Pulmonary Antibody‐Mediated Rejection: Evidence From Cell‐Free DNA Analysis
10.1016/j.healun.2018.01.1305 · 2018 · External reference
Clinical Validation of a Plasma Donor‐Derived Cell‐Free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
10.1097/txd.0000000000001317 · 2022 · External reference
Application of Plasma Donor‐Derived Cell Free DNA for Lung Allograft Rejection Diagnosis in Lung Transplant Recipients
10.1186/s12890-022-02229-y · 2023 · External reference
Circulating Donor‐Derived Cell‐Free DNA as a Marker for Rejection After Lung Transplantation
10.3389/fimmu.2023.1263389 · 2023 · External reference
Cell‐Free DNA in Lung Transplantation: Research Tool or Clinical Workhorse?
10.1097/mot.0000000000000979 · 2022 · External reference
Donor‐Derived Cell‐Free DNA Associated With Increased Risk of Chronic Lung Allograft Dysfunction and Mortality: Are Absolute Levels Better Than Percentage?
10.1016/j.healun.2026.01.022 · 2026 · External reference
Not All HLA Epitope Mismatches Are Equal
10.1016/j.kint.2019.12.017 · 2020 · External reference
Development and Performance of a Next Generation Sequencing (NGS) Assay for Monitoring of Dd‐cfDNA Post Solid Organ Transplantation
10.1016/j.cca.2023.117647 · 2024 · External reference
Cross‐Organ Hierarchy of HLA Molecular Mismatches in Donor‐Specific Antibody Development in Solid Organ Transplantations
10.1016/j.xcrm.2025.102153 · 2025 · External reference
58 Sorting Out the Intricacies of Multiparity Risk on Outcomes After Heart Transplantation
10.1016/j.healun.2011.01.065 · 2011 · External reference
Analysis of Pregnancy‐Induced Anti‐HLA Antibodies Using Luminex Platform
10.1016/j.transproceed.2015.09.032 · 2015 · External reference
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 2025 Annual Report of Heart and Lung Transplantation
10.1016/j.healun.2025.04.014 · 2025 · External reference
Detection of Donor‐Derived Cell‐Free DNA in the Setting of Multiple Kidney Transplantations
10.3389/fimmu.2024.1282521 · 2024 · External reference
HLA and Lung Transplantation
10.1007/s11684-018-0636-x · 2019 · External reference
Possible Significance of Anti‐HLA DQ Antibodies After Lung Transplantation–Single Centre Study
10.1016/j.humimm.2025.111597 · 2025 · External reference
